politics

AstraZeneca CEO Calls for Faster Innovation Among Western Drugmakers

27 Temmuz 2026The Guardian

Pascal Soriot, the CEO of AstraZeneca, has urged Western drugmakers to accelerate their pace of innovation to avoid falling behind, similar to the automotive industry's experience. He emphasized the need for the pharmaceutical sector in the US and Europe to adopt a 'Chinese speed' approach to remain competitive.
AstraZeneca is closely monitoring the growth of China's pharmaceutical industry and is collaborating to bring drugs to global markets.
The pharmaceutical industry has historically been characterized by lengthy research and development timelines, often leading to delays in bringing new drugs to market. As countries like China invest heavily in their biotech sectors, Western firms face the risk of losing their competitive edge if they do not adapt qu…
Soriot's call to action highlights a critical juncture for Western pharmaceutical companies. As competition intensifies from China, which has rapidly advanced its drug development capabilities, the pressure is on established players to innovate more swiftly.

NewsAI özeti

This article reflects the views of the author and does not necessarily represent the views of The Guardian.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.